2m 2m 2m 2m 2m 2m 2m
TEVAPHARMIND SP ADR (TEVA)
NYSE
$37.31-$0.03 (-0.08%)
Price as of Aug 21, 2026 7:53 PM EDT- $43.5BMarket Cap
- 102.28%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TEVAPHARMIND SP ADR (TEVA)
$37.31-$0.03 (-0.08%)
TEVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $37.34 | ||
Change | +$0.53 (+1.44%) | ||
Open | $36.79 | ||
High | $37.75 | ||
Low | $36.65 | ||
Previous Close | $36.81 | ||
Volume | 4,300,155 | ||
30-Day Average Volume | 5,854,171 | ||
1-Week Change | 1.55% | ||
1-Month Change | 19.11% | ||
1-Year Change | 102.28% | ||
3-Year Change | 288.55% | ||
5-Year Change | 308.53% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $39.9B | ||
Market Cap | $43.5B | ||
Enterprise Value | $56.4B | ||
Period: QTR TTM FY | |||
Revenue | $4.1B | ||
Net Income | -$576.0M | ||
Free Cash Flow | $306.0M | ||
EBIT | -$455.0M | ||
EBITDA | -$214.0M | ||
Net Working Capital | -$1.9B | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -264 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 6 | ||
P/E | -76 | ||
PEG | 0 | ||
Price/Free Cash Flow | 142 | ||
Price/Operating Cash Flow | 106 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/27/2017 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/06/2002 | ||
Earnings & Revenue